This site is intended for Healthcare Professionals only.

Apixaban witnessed £280m rise in its cost since 2021/22


Share post:

Atorvastatin, a medicine to treat high blood cholesterol, is the most dispensed drug with 59 million items in England in 2022/23, revealed the NHS Business Services Authority (NHSBSA) on Thursday (8 June).

While Apixaban (an anticoagulant) was the drug with the highest costs of £430 million. Apixaban 5mg tablets had the largest increase in cost between 2021/22 and 2022/23 in England, with an increase of £280 million.

NHSBSA’s annual statistics report ‘Prescription Cost Analysis-England 2022/23’ published also has revealed an eight per cent rise in the prescription items that were dispensed in the community in England.

The report highlighted that in 2022/23, 1.18 billion prescription items were dispensed at a cost of £10.4 billion in the community in England, witnessing an increase of eight per cent  from £9.69 billion in 2021/22.

Compared to 2014/15, the cost has increased by 17 per cent or £1.48 billion. This marks the fourth year in a row where the cost of items dispensed has increased, after seeing a decrease in the previous three years from 2015/16 to 2018/19.

The report also showed the number of drugs and medical devices (such as blood glucose monitors) dispensed in the community in England increased by 3 per cent to 1.18 billion, from 1.14 billion in 2021/22. Compared to 2014/15, this number has increased by 10 per cent.


Please enter your comment!
Please enter your name here

Current Issue December 2023

Related articles

Pfizer says its RSV shot is protective through a second year

Pfizer on Thursday said a single dose of its new respiratory syncytial virus (RSV) vaccine Abrysvo maintained its...

Novavax sees 2024 sales flat to lower, aims to pick up Covid vaccine market share

Covid-19 vaccine maker Novavax on Wednesday said it expects revenue this year to be flat or lower as...

Drugmaker Sandoz to pay $265m to settle US pricing case

Swiss generic drugmaker Sandoz said on Thursday that it would pay $265 million (£209m) to settle a pricing...

Pharmacists critical in helping people to practice self-care with confidence: survey

People are opting to visit pharmacists for self-care and are conscious of the positive impact it can have...